Delivery Systems

Delivery Systems

Oligonucleotide therapeutics have great potential in the therapeutic areas of cancer, acquired immune diseases, congenital genetic disorders, and others. However, a major obstacle to the widespread use of oligonucleotide therapeutics is how to effectively deliver them to target organs and tissues other than the liver. Therefore, it is necessary to develop different delivery systems in practical applications to make oligonucleotide therapeutics more effective in diagnosing and treating diseases.

Alfa Chemistry's liver-targeted delivery technology has developed to a mature level, supporting the rapid development of drug candidates to the clinical stage. Our team of experts is currently exploring new delivery methods and technologies suitable for extrahepatic tissues. Click on the links below to learn more.

Lipid Conjugate-Based Delivery Systems

Learn More

GalNAc Conjugate-Based Delivery Systems

Learn More

Polymeric Nanoparticle-Based Delivery Systems

Learn More

Peptide Conjugate-Based Delivery Systems

Learn More

DNA Nanostructure-Based Delivery Systems

Learn More

Antibody Conjugate-Based Delivery Systems

Learn More

Small Molecule-Based Delivery Systems

Learn More

Our products and services are for research use only and cannot be used for any clinical purposes.

Online Inquiry
Verification code